Deal with iGate marks Patni's entry into BFSI: CEO
LIME Season 2: Case study on Kingfisher Airlines
ICC organizes PSU Excellence Award
See FY11 profit at Rs 70 cr, PAT at Rs 7-7.5 cr: Refex
TT Ltd eyes Rs 550cr topline, Rs 20cr profit this year
The India Insurance Industry: The Road Ahead
Expect to cross Rs 500cr in revenue this yr: Natco Pharma
Jindal Poly eyes Rs 3,000cr rev in '11; 20% growth in '12
Recognising India’s best healthcare providers
Deal with iGate marks Patni's entry into BFSI: CEO
LIME Season 2: Case study on Kingfisher Airlines
ICC organizes PSU Excellence Award
See FY11 profit at Rs 70 cr, PAT at Rs 7-7.5 cr: Refex
TT Ltd eyes Rs 550cr topline, Rs 20cr profit this year
The India Insurance Industry: The Road Ahead
Expect to cross Rs 500cr in revenue this yr: Natco Pharma
Jindal Poly eyes Rs 3,000cr rev in '11; 20% growth in '12
Recognising India’s best healthcare providers
Deal with iGate marks Patni's entry into BFSI: CEO
LIME Season 2: Case study on Kingfisher Airlines
ICC organizes PSU Excellence Award
See FY11 profit at Rs 70 cr, PAT at Rs 7-7.5 cr: Refex
TT Ltd eyes Rs 550cr topline, Rs 20cr profit this year
The India Insurance Industry: The Road Ahead
Expect to cross Rs 500cr in revenue this yr: Natco Pharma
Jindal Poly eyes Rs 3,000cr rev in '11; 20% growth in '12
Recognising India’s best healthcare providers
Deal with iGate marks Patni's entry into BFSI: CEO
LIME Season 2: Case study on Kingfisher Airlines
ICC organizes PSU Excellence Award
See FY11 profit at Rs 70 cr, PAT at Rs 7-7.5 cr: Refex
TT Ltd eyes Rs 550cr topline, Rs 20cr profit this year
The India Insurance Industry: The Road Ahead
Expect to cross Rs 500cr in revenue this yr: Natco Pharma
Jindal Poly eyes Rs 3,000cr rev in '11; 20% growth in '12
Recognising India’s best healthcare providers
Deal with iGate marks Patni's entry into BFSI: CEO
LIME Season 2: Case study on Kingfisher Airlines
ICC organizes PSU Excellence Award
See FY11 profit at Rs 70 cr, PAT at Rs 7-7.5 cr: Refex
TT Ltd eyes Rs 550cr topline, Rs 20cr profit this year
The India Insurance Industry: The Road Ahead
Expect to cross Rs 500cr in revenue this yr: Natco Pharma
Jindal Poly eyes Rs 3,000cr rev in '11; 20% growth in '12
Recognising India’s best healthcare providers
Deal with iGate marks Patni's entry into BFSI: CEO
LIME Season 2: Case study on Kingfisher Airlines
ICC organizes PSU Excellence Award
See FY11 profit at Rs 70 cr, PAT at Rs 7-7.5 cr: Refex
TT Ltd eyes Rs 550cr topline, Rs 20cr profit this year
The India Insurance Industry: The Road Ahead
Expect to cross Rs 500cr in revenue this yr: Natco Pharma
Jindal Poly eyes Rs 3,000cr rev in '11; 20% growth in '12
Recognising India’s best healthcare providers
Deal with iGate marks Patni's entry into BFSI: CEO
LIME Season 2: Case study on Kingfisher Airlines
ICC organizes PSU Excellence Award
See FY11 profit at Rs 70 cr, PAT at Rs 7-7.5 cr: Refex
TT Ltd eyes Rs 550cr topline, Rs 20cr profit this year
The India Insurance Industry: The Road Ahead
Expect to cross Rs 500cr in revenue this yr: Natco Pharma
Jindal Poly eyes Rs 3,000cr rev in '11; 20% growth in '12
Recognising India’s best healthcare providers
Deal with iGate marks Patni's entry into BFSI: CEO
LIME Season 2: Case study on Kingfisher Airlines
ICC organizes PSU Excellence Award
See FY11 profit at Rs 70 cr, PAT at Rs 7-7.5 cr: Refex
TT Ltd eyes Rs 550cr topline, Rs 20cr profit this year
The India Insurance Industry: The Road Ahead
Expect to cross Rs 500cr in revenue this yr: Natco Pharma
Jindal Poly eyes Rs 3,000cr rev in '11; 20% growth in '12
Recognising India’s best healthcare providers
Deal with iGate marks Patni's entry into BFSI: CEO
LIME Season 2: Case study on Kingfisher Airlines
ICC organizes PSU Excellence Award
See FY11 profit at Rs 70 cr, PAT at Rs 7-7.5 cr: Refex
TT Ltd eyes Rs 550cr topline, Rs 20cr profit this year
The India Insurance Industry: The Road Ahead
Expect to cross Rs 500cr in revenue this yr: Natco Pharma
Jindal Poly eyes Rs 3,000cr rev in '11; 20% growth in '12
Recognising India’s best healthcare providers